HRSA Commits $52M to Health Centers Supporting People Leaving Incarceration
The Health Resources and Services Administration is making a $52 million investment in 54 health centers to support the health needs of those leaving incarceration.
Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court
Johnson & Johnson is suing the federal agencies overseeing the 340B program that makes discounted medicines more accessible to uninsured and underserved patients. J&J contends the Health Resources Services Administration can’t legally oppose its plan to implement a new rebate plan for certain 340B drugs.
presented by
How (and Where) to Find the Best Value Rehabilitation Programs for Brain Injuries
Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one.
J&J Backs Down From 340B Rebates, But Maintains They’re ‘Legally Permissible’ Per Statute
Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In other recent regulatory news, we have drug approvals, clinical holds, and one product withdrawal.
J&J’s Change to 340B Discounts is “Inconsistent” with Statute, HRSA Says
Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is "inconsistent" with the 340B statute, according to HRSA.
How Covered Entities and Pharma Companies Can Better Collaborate on Drug Discount Programs
Three things drug manufacturers and CEs can do to build trust and enable effective collaboration
Feds expected to scrutinize Covid-era payments to providers
Hospitals, clinics, nursing homes and other providers collected billions in government aid during the pandemic. Federal auditors may soon come knocking to ensure the money was spent correctly.
presented by
Discover the Most Effective Aquatic Therapy Programs in Chicago Suburbs
Incorporating aquatic therapy can enhance patient outcomes and shorten recovery times for health care professionals. In the Chicago suburbs, the demand for such programs is rising.
In fight over drug discounts, HHS lawyer sides with hospitals
Prominent drug companies have said they want to curb waste and abuse in the 340B Drug Pricing Program. But the top lawyer at HHS is echoing the criticism hospitals have been leveling against the drug companies over access to the program.
Hospitals sue drug companies over discount program
The lawsuit follows action by at least a half-dozen drug companies to rein in what they see as waste and abuse in the program, overseen by the Department of Health and Human Services. Meanwhile, the Hospital plaintiffs have a potentially powerful ally in the person picked to head the department under the incoming Biden administration.